Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with interest the correspondences by Sriram1 and Boman et al.2 concerning the matter of Chlamydia pneumoniae in the central nervous system of patients with MS. Boman et al.3 previously reported the failure to detect C. pneumoniae in the CNS of patients with MS. They also reported that some group might detect C. pneumoniae DNA in the CSF of patients with MS, if the CSF contains circulating white blood cells.2
Layh–Schmitt et al.4 reported that they identified C. pneumoniae in CSF by PCR in MS. Their conclusion is in general agreement with previous studies, but their rate of positive results is lower than in a recent report.4,5⇓
C. pneumoniae is a common etiologic agent that causes acute infection in the respiratory tract. Chlamydial infections are known to become chronic or persistent. However, the clinical spectrum of C. pneumoniae infection other than acute respiratory tract infection has not been completely clarified.6
There is evidence indicating that C. pneumoniae might play an etiologic …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Reply to Parratt et al
- Kei Numazaki, Dept. Pediatrics, Sapporo Medical University, Sapporo, Japannumazaki@sapmed.ac.jp
Submitted December 20, 2001 - Response to letter by Dr. Numazaki
- J Parratt, Clinical Research Fellow, Ninewells Hospital, Dundee, Scotlandjohn.parratt@tuht.scot.nhs.uk
- "R Tavendale, D Parratt, J O O'Riordan, RJ Swingler"
Submitted December 20, 2001
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Recent bacterial and viral infection is a risk factor for cerebrovascular ischemiaClinical and biochemical studiesA. J. Grau, F. Buggle, H. Becher et al.Neurology, January 01, 1998 -
Articles
Infection, inflammation, and cerebrovascular ischemiaArmin J. Grau et al.Neurology, November 01, 1997 -
Review
Potential Neurologic Manifestations of COVID-19Anna S. Nordvig, Kathryn T. Fong, Joshua Z. Willey et al.Neurology: Clinical Practice, June 30, 2020 -
Null Hypothesis
Seasonal influenza vaccine and Guillain-Barré syndromeA self-controlled case series studyClémence Grave, Pauline Boucheron, Jérémie Rudant et al.Neurology, February 25, 2020